NR 565 Advanced Pharmacology Final & Midterm 2026/2027 – 100+ Questions & Answers | Thyroid, Diabetes, Asthma, COPD, GERD, TB & Vaccines – NR 565 | Chamberlain University

This comprehensive NR 565 Advanced Pharmacology Final and Midterm Exam 2026/2027 study resource contains 100+ exam-style questions with accurate answers across 24 pages, covering high-yield pharmacology concepts for advanced nursing practice. Major topics include thyroid pharmacology, diabetes medications and insulin therapy, asthma and COPD treatment, smoking cessation, tuberculosis pharmacotherapy, gastrointestinal medications, GERD and peptic ulcer disease, constipation and diarrhea treatments, vaccines and immunization. The question-and-answer structure emphasizes mechanisms of action, medication selection, contraindications, adverse effects, interactions, laboratory monitoring and essential patient education. The thyroid pharmacology section reviews TSH, T3 and T4 laboratory assessment, hypothyroidism and hyperthyroidism, levothyroxine monitoring and thyroid storm treatment. Students review clinically significant levothyroxine interactions involving calcium, iron, magnesium, antacids, proton-pump inhibitors, phenytoin, carbamazepine, rifampin, sertraline and warfarin. The material also addresses the consequences of untreated hypothyroidism during pregnancy and the use of beta blockers for symptomatic management of hyperthyroidism. A substantial portion focuses on diabetes mellitus and antidiabetic pharmacology, including diagnostic thresholds for A1C, fasting plasma glucose, random glucose and oral glucose tolerance testing. The guide examines metformin, insulin, GLP-1 receptor agonists, thiazolidinediones (TZDs), DPP-4 inhibitors, SGLT2 inhibitors and sulfonylureas, along with their mechanisms of action and major prescribing considerations. Insulin content includes basal-versus-bolus dosing, total daily dose and carbohydrate-to-insulin calculations. Pioglitazone precautions involving heart failure and bladder cancer are also reviewed. The respiratory pharmacology material provides targeted preparation in asthma and COPD management. Students differentiate intermittent, mild-persistent, moderate-persistent and severe-persistent asthma and review SABAs, LABAs, inhaled corticosteroids, oral corticosteroids, LAMAs and roflumilast. Specific medications include albuterol, levalbuterol, formoterol, salmeterol, beclomethasone and budesonide. Questions emphasize bronchodilation, airway inflammation, appropriate rescue-inhaler use, monitoring SABA frequency, inhaler technique and peak expiratory flow. Smoking-cessation content reviews nicotine replacement therapy and bupropion, including nicotine patches, gum and nasal spray, treatment duration and patient counseling. Infectious-disease pharmacology includes multidrug-resistant and extensively drug-resistant tuberculosis, isoniazid, rifamycin therapy and pyridoxine supplementation, while upper-respiratory material reviews phenylephrine, pseudoephedrine, oxymetazoline and other decongestants. The gastrointestinal section covers H2-receptor antagonists, proton-pump inhibitors, H. pylori therapy, peptic ulcer disease, antidiarrheals, laxatives and antiemetics/prokinetic therapy. Students review cimetidine-related CYP450 interactions, long-term PPI concerns involving calcium, magnesium and vitamin B12, GERD treatment, bismuth subsalicylate, psyllium and metoclopramide. Important safety concepts include the association between salicylates and Reye syndrome in children and metoclopramide's boxed warning regarding tardive dyskinesia. The final portion provides focused review of vaccines and immunology, including Tdap/DTaP, varicella, hepatitis vaccines, MMR, influenza, rotavirus and poliovirus vaccines. Students differentiate live, attenuated, inactivated and toxoid vaccines and review vaccine contraindications, post-vaccination adverse effects, active versus passive immunity and herd immunity. Rabies post-exposure prophylaxis is also addressed through questions on human rabies immune globulin and vaccine administration. Relevant students: This resource is especially relevant for NR 565 students, Chamberlain University graduate nursing students, MSN students, Family Nurse Practitioner students, nurse practitioner students, APRN students and other advanced nursing learners preparing for pharmacology midterm or final examinations. It is useful for active recall, rapid exam revision and strengthening knowledge of drug classes, mechanisms, interactions, contraindications, clinical monitoring and patient teaching. Keywords: NR 565 Advanced Pharmacology, NR 565 final exam , NR 565 midterm exam , NR 565 questions and answers, Chamberlain NR 565, Advanced Pharmacology exam, Advanced Pharmacology questions and answers, nurse practitioner pharmacology, FNP pharmacology, thyroid pharmacology, levothyroxine, hyperthyroidism treatment, hypothyroidism treatment, diabetes pharmacology, insulin therapy, metformin, GLP 1 receptor agonists, SGLT2 inhibitors, DPP 4 inhibitors, sulfonylureas, asthma pharmacology, COPD pharmacology, SABA, LABA, inhaled corticosteroids, roflumilast, smoking cessation pharmacology, nicotine replacement therapy, tuberculosis pharmacology, GERD pharmacology, proton pump inhibitors, H2 receptor antagonists, H pylori treatment, gastrointestinal pharmacology, metoclopramide, vaccine pharmacology, immunization, active immunity, passive immunity, rabies post exposure prophylaxis